158 related articles for article (PubMed ID: 31040883)
1. New technologies in the management of overactive bladder: current research and future prospects.
Marinkovic SP
Ther Adv Urol; 2019; 11():1756287219844669. PubMed ID: 31040883
[TBL] [Abstract][Full Text] [Related]
2. New Devices and Technologies for the Management of Overactive Bladder.
Guzman-Negron JM; Goldman HB
Curr Urol Rep; 2017 Oct; 18(12):94. PubMed ID: 29046985
[TBL] [Abstract][Full Text] [Related]
3. Prospective Trial of Sacral Neuromodulation for Refractory Overactive Bladder Syndrome in Korean Patients.
Moon KH; Han JY; Kim JH; Lee HN; Lee KS; Lee JG; Oh SJ; Yoon HN; Choo MS
Low Urin Tract Symptoms; 2014 Sep; 6(3):175-9. PubMed ID: 26663601
[TBL] [Abstract][Full Text] [Related]
4. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
[TBL] [Abstract][Full Text] [Related]
5. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.
Martinson M; MacDiarmid S; Black E
J Urol; 2013 Jan; 189(1):210-6. PubMed ID: 23174264
[TBL] [Abstract][Full Text] [Related]
6. Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome.
Noblett KL; Dmochowski RR; Vasavada SP; Garner AM; Liu S; Pietzsch JB
Neurourol Urodyn; 2017 Mar; 36(3):727-733. PubMed ID: 27062384
[TBL] [Abstract][Full Text] [Related]
7. Nonantimuscarinic treatment for overactive bladder: a systematic review.
Olivera CK; Meriwether K; El-Nashar S; Grimes CL; Chen CC; Orejuela F; Antosh D; Gleason J; Kim-Fine S; Wheeler T; McFadden B; Balk EM; Murphy M;
Am J Obstet Gynecol; 2016 Jul; 215(1):34-57. PubMed ID: 26851599
[TBL] [Abstract][Full Text] [Related]
8. [Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder].
Mazo EB; Krivoborodov GG
Zh Vopr Neirokhir Im N N Burdenko; 2002; (1):17-21. PubMed ID: 12046321
[TBL] [Abstract][Full Text] [Related]
9. Where Are We Headed with Neuromodulation for Overactive Bladder?
Jaqua K; Powell CR
Curr Urol Rep; 2017 Aug; 18(8):59. PubMed ID: 28656519
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of novel therapies for overactive bladder.
Mayr CA; Shepherd JP
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):527-35. PubMed ID: 24809616
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation for female pelvic floor disorders.
El-Azab AS; Siegel SW
Arab J Urol; 2019 Mar; 17(1):14-22. PubMed ID: 31258941
[No Abstract] [Full Text] [Related]
12. Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder.
Gill BC; Pizarro-Berdichevsky J; Bhattacharyya PK; Brink TS; Marks BK; Quirouet A; Vasavada SP; Jones SE; Goldman HB
J Urol; 2017 Dec; 198(6):1379-1385. PubMed ID: 28645869
[TBL] [Abstract][Full Text] [Related]
13. Device evaluation: eCoin #x2013; implantable tibial nerve stimulator for overactive bladder.
Bressington MJ; Scholtz D; Hooshiary A; Vermeulen W; Burns T; Ordones F; Gilling P
Expert Rev Med Devices; 2023; 20(11):899-904. PubMed ID: 37691269
[TBL] [Abstract][Full Text] [Related]
14. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.
Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T
Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726
[TBL] [Abstract][Full Text] [Related]
15. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A
J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936
[TBL] [Abstract][Full Text] [Related]
16. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.
Chughtai B; Clemens JQ; Thomas D; Sun T; Ghomrawi H; Sedrakyan A
J Urol; 2020 Jan; 203(1):179-184. PubMed ID: 31347949
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery.
Le NB; Kim JH
Curr Bladder Dysfunct Rep; 2011 Mar; 6(1):25-30. PubMed ID: 21461046
[TBL] [Abstract][Full Text] [Related]
18. Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapy.
Ridout AE; Yoong W
J Obstet Gynaecol; 2010 Feb; 30(2):111-4. PubMed ID: 20143965
[TBL] [Abstract][Full Text] [Related]
19. What Is New in Neuromodulation?
Moore CK; Rueb JJ; Derisavifard S
Curr Urol Rep; 2019 Aug; 20(9):55. PubMed ID: 31388779
[TBL] [Abstract][Full Text] [Related]
20. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
